Skip to main content

Table 3 Plasma variables that significantly differ between T1DM and control subjects by univariate statistics

From: Metabolic profiling of type 1 diabetes mellitus in children and adolescents: a case–control study

VAR

Spectral range (ppm)

Assigned metabolite

Relative concentration

Increased/decreased in T1DM

p value*

%-change

T1DM

Controls

18

5.4300–5.2752

HC=CH– in fatty acid chain

21.95 ± 3.63

30.95 ± 4.00

0.001

−29.1

24

4.4100–4.3159

C1 H and C3 H in glycerol backbone of triglycerides + OCH 2 of choline in sphingomyelin/phosphatidylcholine

3.28 ± 1.16

5.09 ± 1.16

0.005

−35.6

34

4.0310–4.0136

l-Serine

0.70 ± 0.26

1.21 ± 0.22

0.003

−42.1

35

4.0136–4.0010

l-Serine

0.84 ± 0.28

1.29 ± 0.23

0.008

−34.9

38

3.9590–3.8330

d-Glucose

91.99 ± 16.9

64.44 ± 6.58

0.004

42.8

41

3.7956–3.7820

d-Glucose

7.62 ± 0.60

6.18 ± 0.60

<0.001

23.3

42

3.7820–3.7550

d-Glucose

30.58 ± 5.63

20.56 ± 1.95

0.003

48.7

43

3.7550–3.7390

d-Glucose

17.92 ± 3.83

11.85 ± 1.35

0.005

51.2

44

3.7390–3.7141

d-Glucose

17.76 ± 3.24

13.05 ± 1.49

0.007

36.1

51

3.5914–3.5649

d-Glucose

14.45 ± 2.19

10.20 ± 1.06

0.002

41.7

52

3.5649–3.5510

d-Glucose

5.84 ± 1.10

3.65 ± 0.50

0.002

60.0

54

3.5360–3.3980

d-Glucose

116.37 ± 30.40

69.27 ± 8.54

0.005

68.0

55

3.3980–3.3765

l-Tryptophan

0.70 ± 0.32

1.94 ± 0.41

<0.001

−63.9

63

3.1090–3.0860

l-Cysteine

2.28 ± 0.47

3.05 ± 0.39

0.006

−25.2

91

2.1230–1.9720

–CH 2–CH=CH– in fatty acid chain

53.13 ± 7.19

64.03 ± 3.76

0.007

−17.0

100

1.3450–1.2458

CH3–(CH 2)n– in fatty acid chain

117.69 ± 17.62

155.40 ± 22.01

0.004

−24.3

110

0.9660–0.8000

CH 3–(CH2)n– in fatty acid chain

89.10 ± 14.79

111.75 ± 7.83

0.006

−20.3

  1. * Benjamini–Hochberg adjusted p value, calculated using the independent samples t test. %-change is the increase (+) or decrease (−) of the mean in the T1DM group with respect to the control group
  2. VAR variable